baber/WOPTO huggingface dataset:
Patent AU-672757-B2 (AU)
Title: Dynamometric screw or nut
Inventor: WATTERBACK PAUL GUNNAR
IPC: F16B31/02
Filed: 1992-07-15
Granted: 1996-10-17
Abstract: PCT No. PCT/SE92/00519 Sec. 371 Date May 16, 1995 Sec. 102(e) Date May 16, 1995 PCT Filed Jul. 15, 1992 PCT Pub. No. WO94/02749 PCT Pub. Date Feb. 3, 1994A torque nut or screw that allows the nut to be tightened to a preset maximum torque, but prevents excess tightening. The nut or screw includes inner and outer threaded elements that extend along the same axis. The outer threaded element is tapered with respect to the axis. The fastener includes an inner fastening member (7) having fastening threads (8) and an outer female member (10) that is rotatable by means of a spanner, a pair of pliers, a screw driver, or other tool. The female member is connected to the inner fastening member by a coupling (13) having a sufficient strength to transfer to the inner fastening member a torque of a magnitude for which the fastening device is designed. The outer female member (10) is designed to be released upon tightening of the coupling and rotated relative to the inner fastening member (7), but not until the predetermined torque is exceeded. The coupling between the outer female (10) and the inner fastening member (7) includes a conical screw coupling.
Patent AU-704904-B2 (AU)
Title: Manufacture of paper
Inventor: CUTTS PAUL KENNETH
IPC: D21H17/37
Filed: 1995-06-01
Granted: 1999-05-06
Abstract: Paper is made by forming a thick stock cellulosic suspension, flocculating the thick stock by adding a relatively high molecular weight and relatively low cationic charge density polymer, diluting the flocculated thick stock to form a thin stock and then draining the thin stock to form a sheet. Usually coagulant is added to the thin stock before drainage and best results are achieved by adding coagulant followed by anionic colloidal material such as bentonite. The process can be operated to give good retention and good formation and, if the thick stock is dirty, to minimise pitch problems.
Patent AU-615250-B2 (AU)
Title: Bandages
Inventor: PEARCE RICHARD HUGH
IPC: A61F13/04
Filed: 1989-01-23
Granted: 1991-09-26
Abstract: A knitted substrate suitable for use in a resin-coated, water-hardenable orthopaedic splinting bandage is described. The substrate comprises inelastic fibres being incorporated in the substrate in the length direction. In a preferred substrate the low modulus fibre is a multifilament polypropylene and the elastic fibre is a polyurethane yarn. Conformable orthopaedic bandages employing the substrate are also described.
Patent AU-688538-B2 (AU)
Title: A dilator for outer wall tissues of human anatomy
Inventor: JOHNSON BRUCE C
IPC: A61F2/82
Filed: 1995-06-30
Granted: 1998-03-12
Abstract: A dilator formed with a truss with a pair of spaced-apart end surfaces that provides a restoring force therebetween if forced toward one another, this restoring force provided by a resilient band extending between the opposite ends of the truss with a plurality of notches at each end thereof. The notches exceed at least a third of the thickness of the band. A second and similar band may also be provided in the truss.
Patent AU-688072-B2 (AU)
Title: Heterocyclic tachykinin receptor antagonists
Inventor: CHO SUNG-YONG STEPHEN
IPC: A61P43/00
Filed: 1995-06-30
Granted: 1998-03-05
Abstract: This invention provides the novel compound of the following formula   <CHEM> having the chemical name (R)-3-(1H-indol-3-yl)-1-ÄN-(2-methoxybenzyl)acetylaminoÜ-2-ÄN-(2-(4-(p iperidin-1-yl)piperidin-1-yl)acetyl)aminoÜpropane dihydrochloride trihydrate.
Patent AU-612244-B2 (AU)
Title: Process for elimination of mercury and possibly arsenic in hydrocarbons
Inventor: ROUSSEL MICHEL
IPC: C10G67/06
Filed: 1989-03-09
Granted: 1991-07-04
Abstract: Process for elimination of mercury in hydrocarbon charges wherein said charge is contacted, under hydrogen, with a catalyst containing at least one metal from the group consisting of nickel, cobalt, iron and palladium followed by-or mixed with-a capture mass containing sulfur or a metal sulfide.
Patent AU-720091-B2 (AU)
Title: Telecommunication system
Inventor: WERFF MARTIN REMCO VAN DER
IPC: H04B7/185
Filed: 1997-06-05
Granted: 2000-05-25
Abstract: Telecommunication system in which local terminals may be called from one or more central stations by way of transmission paths selected by selection device on the probability of success. Selection takes place with the help of selection tables on the basis of exchanged signalling messages obtained from, or by way of, a switching system (3); other selection tables are also possible, e.g., on the basis of geographic or cartographic information. To the transmission paths there are assigned scores on the basis of the points in time of successful and unsuccessful calls, and of numbers of successful calls. During a session, a call is first made by way of the transmission path having the highest score (S(ok), S(nok) or S(rc)) in one of the selection tables (OK, NOK and RC, respectively). In the event of failure, the call is repeated by way of a preferred transmission path (PP), once again in sequence of the scores from one of the selection tables. If these calls are unsuccessful as well, the other transmission paths are tested, once again in sequence of the scores (S(ok), S(nok) or S(rc)) from one of the selection tables (OK, NOK and RC, respectively). Transmission paths for which it is a short while ago (e.g., less than 5 minutes) that an unsuccessful call took place, are not used. All this is useful, inter alia, for Inmarsat, GSM, UMTS and UPT.
Patent AU-575342-B2 (AU)
Title: Gamma - butyrolactone derivatives
Inventor: OGURI TOMEI
IPC: C07D307/32
Filed: 1984-09-10
Granted: 1988-07-28
Abstract: There are disclosed a  gamma -butyrolactone derivative represented by the following formula 
<CHEM>
 wherein R<1>, R<2>, R<3> and X each represent a group or an atom as defined in the specifation;
 a process for preparing the same and an immunomodulating composition containing the same as an active ingredient.
Patent AU-624138-B2 (AU)
Title: New antiviral drug
Inventor: SUDA ISAO
IPC: A61K31/70
Filed: 1989-05-12
Granted: 1992-06-04
Abstract: An antiviral drug containing N-acetyl-3-fluoroneuraminic acid having the following formula: <CHEM> or a pharmacologically acceptable salt thereof is disclosed in the present application.
Patent AU-631544-B2 (AU)
Title: Amphibious craft
IPC: B60F3/00
Filed: 1989-04-28
Granted: 1992-12-03
Abstract: An amphibious craft has a hull and wheels for supporting the hull on land. At least one pair of the wheels is driven from a motor on the craft. The driven wheels (13) on one side of the craft are driven independently from those on the other side of the craft. To this end respective drive transmission mechanisms (28, 29, 31; 33, 34) are provided for the wheels to transfer power from the main drive shaft (15) to the wheel stub axles (20). Each drive transmission mechanism is housed in a watertight casing which also acts as the main strut for the wheel when in use. The wheels are retractable into respective compartments in the hull preferably without breaking the strength of the keel.
Patent AU-715779-B2 (AU)
Title: Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and method of reducing TNF-alpha levels
Inventor: MULLER GEORGE W
IPC: A61P9/04
Filed: 1997-07-24
Granted: 2000-02-10
Abstract: Substituted 2-(2,6-dioxopiperidin-3-yl)phthalimides and 1-oxo-2-(2,6-dioxopiperidin-3-yl)isoindolines reduce the levels of TNF± in a mammal. Typical embodiments are 1-oxo-2-(2,6-dioxo-3-methylpiperidin-3-yl)-4,5,6,7-tetrafluoroisoindoline and 1,3-dioxo-2-(2,6-dioxo-3-methylpiperidin-3-yl)-4-aminoisoindoline.
Patent AU-651930-B2 (AU)
Title: Method of retarding fouling of an underwater surface of a marine structure
Inventor: GRUENING RAINER
IPC: C09D5/16
Filed: 1993-06-10
Granted: 1994-08-04
Abstract: A synergistic composition of biocides for the preparation of anti-fouling paint preferably containing at least one of the group of 3-iodo-2-propynyl-butyl carbamate, 3-iodo-2-propynyl-cyclohexyl carbamate, 3-iodo-2-propynyl phenyl carbamate, 3-iodo-2-propynyl-benzyl carbamate, 3-iodo-2-propynyl propyl carbamate and 4-iodo-3-butynyl propyl carbamate and at least one of the group of tributyltin compounds consisting of bis(tributyltin) oxide, tributyltin fluoride, tributyltin methacrylate, tributyltin phosphate and tributyltin naphthenate. Said composition is more effective in protecting ship bottoms or underwater constructions than each component itself.
Patent AU-765118-B2 (AU)
Title: Polymer particle vaccine delivery system
Inventor: CARLSSON HANS
IPC: A61K47/42
Filed: 1999-04-09
Granted: 2003-09-11
Abstract: The present invention concerns polymer particle vaccine delivery systems in which a water insoluble protein antigen, e.g. a lipidated HpaA protein, is incorporated with particles comprising a polymer matrix. The present invention also concerns a method for incorporating such a water insoluble protein antigen with a polymer matrix in order to produce a polymer particle vaccine delivery system. In addition, the invention also provides a vaccine composition comprising the polymer particle delivery system. The vaccine can be used to treat and/or reduce the risk of for example Helicobacter infection.
Patent AU-665256-B2 (AU)
Title: Branched alkylamino derivatives of thiazole, processes for preparing them and pharmaceutical compositions containing them
Inventor: COURTEMANCHE GILLES
IPC: C07D277/44
Filed: 1993-06-22
Granted: 1995-12-21
Abstract: The subject of the invention is the derivatives of formula I: <IMAGE>  in which,   R1 represents a phenyl or naphthyl radical (optionally substituted),   R2 represents a hydrogen or halogen atom or an alkyl, hydroxymethyl or formyl radical, R3 represents an alkyl, cycloalkyl, alkenyl, cycloalkyalkyl or phenyl radical, R4 represents a hydrogen atom or an alkyl, cycloalkyl or cycloalkylalkyl radical, R5 represents an alkyl, cycloalkyl, cycloalkylalkyl or alkenyl radical or a radical of formula B: <IMAGE>  (p = 0, 1, 2 or 3), - R6 represents an optionally substituted phenyl, pyridyl, imidazolyl, pyrrolyl, thienyl or furyl radical or a cycloalkyl radical, - m and n, which are identical or different, each represent 0 or 1,   their possible stereoisomers and their addition salts. MEDICAMENTS.
Patent AU-688185-B2 (AU)
Title: Oral compositions containing dimethicone copolyols
Inventor: HUGHES IAIN ALLAN
IPC: A23L27/00
Filed: 1995-11-21
Granted: 1998-03-05
Abstract: An oral composition in the form of a toothpaste, powder, liquid dentifrice, mouthwash, denture cleanser, chewing gum or candy comprising a lipophilic compound selected from flavorants, physiological cooling agents and antimicrobial compounds and a dimethicone copolyol selected from alkyl- and alkoxy-dimethicone copolyols having formula (I) wherein X is selected from hydrogen, alkyl, alkoxy and acyl groups having from about 1 to about 16 carbon atoms, Y is selected from alkyl and alkoxy groups having from about 8 to about 22 carbon atoms, n is from about 0 to about 200, m is from about 1 to about 40, q is from about 1 to about 100, the molecular weight of the residue (C2H4O-)x(C3H6O-)yX is from about 50 to about 2000, and x and y are such that the weight ratio of oxyethylene:oxypropylene is from about 100:0 to about 0:100. The composition provides improved antiplaque and anti-bacterial activity together with enhanced substantivity, impact and/or efficacy of the lipophilic components on teeth or dentures.
Patent AU-624187-B2 (AU)
Title: Pharmaceutical compositions containing nitroxyalkylamines, new nitroxyalkylamines and processes for the preparation thereof
Inventor: SIMON HERBERT
IPC: C07C235/40
Filed: 1989-10-19
Granted: 1992-06-04
Abstract: The present invention provides pharmaceutical compositions effective against angina-like heart and circulatory diseases containing at least one nitroxyalkylamine derivative of the general formula: <IMAGE> (I)  wherein R1 is a hydrogen atom, a lower-alkyl radical, a C3-C8-cycloalkyl or C3-C8-cycloalkenyl radical, an aminocarbonyl, C1-C6-mono- or di-alkylaminocarbonyl radical, R2 is a hydrogen atom, a lower-alkyl radical or a C3-C8-cycloalkyl or cycloalkenyl radical or R2, together with R1 and the nitrogen atom to which they are attached, form a heteroaliphatic ring containing up to 6 carbon atoms, A is a valency bond or a straight-chained or branched lower-alkylene radical, in which a -CH2- group can be replaced by a cycloalkylene radical, B is a lower-alkylene radical, in which a -CH2- group can be replaced by a cycloalkylene radical and X is an -NR3-CO- or -CO-NR3- radical, in which R3 is a hydrogen atom or a lower-alkyl radical, when X is an -NR3-CO- radical, R3, together with the nitrogen atom and a carbon atom of the group A, bridge a heterocyclic ring containing 4 to 6 carbon atoms or R3, together with R2, A and the two nitrogen atoms, bridge a heterocyclic ring containing 3 to 5 carbon atoms; and the optically-active forms and physiologically acceptable salts thereof.
Patent AU-636857-B2 (AU)
Title: Anti-thrombins polypeptides derived from hirudinaria manillensis
IPC: A61K38/04
Filed: 1989-11-13
Granted: 1993-05-13
Abstract: A polypeptide derived from leeches of the species Hirudinaria manillensis has the following amino-acid sequence: X-Y-tyr-thr-asp-cys-thr-glu-ser-gly-gln-asn-tyr-cys-leu-cys-val-gly-se r-asn-val- cys-gly-glu-gly-asp-asn-cys-asn-D- gln-leu-ser-ser-ser-gly-asn-gln-cys-val-E-gly-glu-gly-thr- pro-F-pro-gln-ser-gln-thr-glu-gly-asp-phe-glu-glu-ile-pro-asp-glu-Z-il e-lys; wherein X indicates any amino acid reisude; Y indicates any amino acid residue; Z indicates any amino acid residue; D indicates cys or pro; and E indicates glu or asp or his; F indicates asp, lys or trp; or a pharmaceutically acceptable salt, derivative or bioprecursor thereof. The polypeptide, and fragments thereof, is a specific anti-thrombin useful as a medicament.
Patent AU-749806-B2 (AU)
Title: Temperature-sensitive liposomal formulation
Inventor: NEEDHAM DAVID
IPC: A61K31/517
Filed: 1999-06-09
Granted: 2002-07-04
Abstract: Temperature sensitive liposomes containing active agents are described. The liposomes comprise phospholipids and a surface active agent, such as a lysolipid, that increases the amount of active agent released by the liposome at the phase transition temperature of the liposome. Such liposomes are useful in methods of administering active agents using mild hyperthermic conditions.
Patent AU-631167-B2 (AU)
Title: Superficial therapeutic system comprising an anti-neoplastic active substance, particularly 5-fluorouracil
IPC: A61K47/10
Filed: 1989-12-29
Granted: 1992-11-19
Abstract: The invention relates to a surface treatment system consisting of an impermeable backing layer, of an agent-containing matrix and of a protective layer which can be detached again, where the matrix contains:
 a. an antineoplastic agent
 b. a self-adhesive polyacrylate
 c. a water absorber
 and where appropriate
 d. a non-adhesive hydrophilic polyacrylate
 e. an emollient and/or penetration promoter.
Patent AU-713959-B2 (AU)
Title: Method and apparatus for manufacturing objects having optimized response characteristics
Inventor: VILLE JAMES A ST
IPC: G06F17/50
Filed: 1996-02-14
Granted: 1999-12-16
Abstract: A method for manufacturing an object having a potential {x} which is generated in response to a field {f} applied thereto is provided. The method includes the step of designing a geometric model of the object. A computerized mathematical model of the object is generated by discretizing the geometric model of the object into a plurality of finite elements and defining nodes at boundaries of the elements, wherein values of the field {f} and potential {x} are specified at the nodes. A material property matrix [k] is then calculated based on the relationship {f}=[k] {x}. Material property coefficients are then extracted from the material property matrix [k] for each finite element in the computerized mathematical model and the extracted material property coefficients are compared to material property coefficients for known materials to match the extracted material property coefficients to the material property coefficients for known materials. Manufacturing parameters corresponding to the matched material property coefficients are then determined. The object is then manufactured in accordance with the determined manufacturing parameters.
Patent AU-689080-B2 (AU)
Title: Method of preparing taxane derivatives
Inventor: MAS JEAN-MANUEL
IPC: A61K31/337
Filed: 1993-10-04
Granted: 1998-03-26
Abstract: PCT No. PCT/FR93/00967 Sec. 371 Date May 3, 1995 Sec. 102(e) Date May 3, 1995 PCT Filed Oct. 4, 1993 PCT Pub. No. WO94/07877 PCT Pub. Date Apr. 14, 1994This invention relates to a method of preparing taxane derivatives of general formula (I) by esterification of protected baccatine III or 10-deacetylbaccatine III by means of an acid of general formula (VII), elimination of protection groupings of the ester obtained, and acylation of the amine function of the side chain. In formulae (I) and (VII): Ar stands for aryl, R is hydrogen or acetyl, R1 is benzoyl or R2-CO-O- in which R2 is alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, bicycloalkyl, phenyl or heterocyclyl, R3 and R4 may be the same or different and represent hydrogen, alkyl, alkenyl, aralkyl, aryl or alkoxy, and R5 is an alkyl radical substituted by one or more chlorine atoms (2,2,2-trichloroethyl, (2-trichloromethylisopropyl).    <IMAGE>  (I)   <IMAGE>  (VII)
Patent AU-651556-B2 (AU)
Title: Method and apparatus for controlling the relative humidity in concrete and masonry structures
Inventor: UTKLEV KJELL
IPC: E04B1/62
Filed: 1990-03-12
Granted: 1994-07-28
Abstract: PCT No. PCT/NO90/00049 Sec. 371 Date Sep. 26, 1991 Sec. 102(e) Date Sep. 26, 1991 PCT Filed Mar. 12, 1990 PCT Pub. No. WO90/10767 PCT Pub. Date Sep. 20, 1990.In a method for eliminating humidity from concrete and masonry structures by means of electroosmosis, current pulses which are supplied in a determined pattern are used. The pulse voltage is limited to +/-40 V. In order to generate the pulses and feed the electrodes a special electronic control device is used.
Patent AU-713659-B2 (AU)
Title: Preparation and use of composite particles containing diacyl peroxide
Inventor: PAINTER JEFFREY DONALD
IPC: C11D3/37
Filed: 1996-03-27
Granted: 1999-12-09
Abstract: There is provided a process for ma ing composite particulates comprising from about 1% to about 50% by weight of discrete particles of water-insoluble diacyl peroxide having a mean particle size of less than about 300 microns and from about 30% to about 99% by weight of a carrier material which melts in the range of from about 38 DEG  C. to about 77 DEG  C. This preparation process involves the steps of (i) mixing the particles of water-insoluble diacyl peroxide into the carrier material while the carrier material is in a molten state and then (ii) rapidly cooling and solidifying the resultant mixture and thereafter (iii) wor ing the solidified mixture if or as necessary to form the composite particulates therefrom. Detergent compositions containing the composite particulates are also provided.
Patent AU-614228-B2 (AU)
Title: Treatment of woollen textile material
Inventor: HEYWOOD DEREK WALLWORK
IPC: D06M15/572
Filed: 1990-04-23
Granted: 1991-08-22
Abstract: In a process for the treatment of woollen textile material, which may be in the form of yarn or fabric, to reduce shrinkage and felting and improve resistance to abrasion, by depositing a polyamide-epichlorhydrin resin thereon, the material is given a subsequent treatment with an aqueous polyurethane dispersion. The polyurethane thus deposited adds to the improvement in properties brought about by the polyamide-epichlorhydrin resin. The woollen textile material to be treated, especially when in the form of yarn, may comprise wool admixed with other (particularly synthetic) fibre, such as fibres of viscose, polyesters and especially polyamides, such as nylon.
Patent AU-600895-B2 (AU)
Title: Biologically active lysine containing octapeptides
Inventor: SCHALLY ANDREW V
IPC: C07K14/655
Filed: 1986-04-17
Granted: 1990-08-30
Abstract: Novel compositions of the formulawhereinA represents an L, D or DL amino-acid selected from the group consisting of Ala, Val, Phe, p-CI-Phe, Trp, Pro, Ser, Thr, Glu, Gly, Beta Ala, Abu, N-Me Ala, 5-F-Trp, 5-Br-Trp, 5-Cl-Trp, their acetylated derivatives or a pharmaceutically acceptable acid addition salt thereof;B represents an L, D or DL amino acid amide selected from the group consisting of Thr NH<sub>2</sub>, Val NH,, Pro NH<sub>2</sub>, HO-Pro NH<sub>2</sub>, Ser NH<sub>2</sub>, Tyr NH2, Trp NH<sub>2</sub>, 5-F-Trp NH,, For-Trp NH., Ala NH<sub>2</sub>, Gly NH2, Me Ala NH<sub>2</sub>;X represents L-Phe or L-Tyr,Y represents L-Thr or L-Val;Z is L, D or DL-5-F-Trp, 5-Br-Trp, 5-C1-Trp, 5-I-Trp or D-Trp; andC" and C' represent L or D Cys, Abu, Asp or Lys; provided that where C' is Cys, C" is also Cys and where C' or C" are other than Cys, C" is different from C' and is other than Cys and the pharmaceutically acceptable acid addition salts thereof; are useful as agents for inhibiting the release of growth hormone, for the treatment of gastrointestinal disorders and for therapy of certain cancers and the management of diabetes. These biologically active octapeptides all possess a terminal amino acid amide at position 8 and are prepared by solid phase methods.
Patent AU-751194-B2 (AU)
Title: Extended release acetaminophen
Inventor: CLEMENTE EMMETT
IPC: A61K9/52
Filed: 1999-09-03
Granted: 2002-08-08
Abstract: An extended release acetaminophen composition comprises a plurality of discrete particles containing acetaminophen which, when contained within a gelatin capsule and assayed in a USP Apparatus I rotating basket at 50 rpm in 900 mL of phosphate buffer at pH 5.8 and 37 DEG  C., exhibits about 40 percent to about 53 percent acetaminophen dissolution at one-half hour, about 50 percent to about 68 percent dissolution at 45 minutes, about 57 percent to about 77 percent acetaminophen dissolution at one hour, and about 82 percent to about 92 percent acetaminophen dissolution at two hours. After six hours, the contemplated extended release acetaminophen composition exhibits substantially complete dissolution. A process for treating a human patient with the extended release acetaminophen composition is also disclosed.
Patent AU-706022-B2 (AU)
Title: Process for manufacturing thin strip of perritic stainless steel, and thin strip thus obtained
Inventor: PARADIS PHILIPPE
IPC: B22D11/00
Filed: 1998-05-12
Granted: 1999-06-03
Abstract: Manufacture of less than 10 mm thick strip of ferritic stainless steel (  NOTGREATER  0.012% C,  NOTGREATER  1% Mn,  NOTGREATER 1% Si, NOTGREATER  0.040% P,  NOTGREATER  0.030% S and 16-18% Cr) involves (a) (naturally) cooling twin-roll continuously cast strip without holding in the austenitic transformation region; (b) optionally hot rolling at 900-1150 degrees C with ≥ 5% thickness reduction; (c) coiling at between 600 degrees C and the martensitic transformation temperature (Ms); (d) cooling at  NOTGREATER  300 degrees C/hr. to between 200 degrees C and ambient temperature; and (e) bell annealing, preferably at 800-850 degrees C for ≥ 4 hrs. Preferably, step (a) is carried out by cooling the strip immediately after leaving the casting rolls, at ≥ 10 degrees C/sec. down to 600 degrees C. Also claimed is ferritic stainless steel strip made by the above process.